A randomized, double‐blind, placebo‐controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study
Author:
Affiliation:
1. Department of Geriatrics and Palliative MedicineIcahn School of Medicine at Mount SinaiNew YorkNYUSA
2. James J Peters VA Medical CenterBronxNYUSA
3. Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkNYUSA
Funder
U.S. Department of Veterans Affairs
Alzheimer's Association
Alzheimer Disease Research Center
Department of Veterans Affairs
Publisher
Wiley
Subject
Psychiatry and Mental health,Neurology (clinical)
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2018.09.009
Reference35 articles.
1. Strategies for disease modification in Alzheimer's disease
2. A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
3. Comprehensive, Individualized, Person‐Centered Management of Community‐Residing Persons with Moderate‐to‐Severe Alzheimer Disease: A Randomized Controlled Trial;Reisberg B.;Dement Geriatr Cogn Disord,2017
4. Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
5. Alzheimer's disease drug development pipeline: 2018
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Latest Perspectives on Alzheimer’s Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems;Molecules;2024-08-27
2. Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08
3. Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications;Ageing Research Reviews;2024-07
4. Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer’s Disease: Findings from Clinical Trials;Journal of Alzheimer's Disease;2024-06-12
5. Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders;Brain Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3